Article Text

other Versions

PDF
Original article
Survey of feasibility of a peelable and point-of-use labelling system
  1. Miriam Klein,
  2. Henry Cohen
  1. Kingsbrook Jewish Medical Center, Brooklyn, New York, USA
  1. Correspondence to Dr Miriam Klein, Assistant Director of Pharmacy, Medication Safety, Kings County Hospital Center, Department of Pharmacy, 451 Clarkson Avenue, Brooklyn, New York, 11203, USA; mkpharmacy{at}yahoo.com Henry Cohen, MS, PharmD, FCCM, BCPP, CGP, Chief Pharmacotherapy Officer, Director of Pharmacy Residency Programs (PGY-1 & PGY-2), Kingsbrook Jewish Medical Center, Department of Pharmacy Services, 585 Schenectady Avenue, Brooklyn, New York, 11203, USA; Professor of Pharmacy Practice, Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, New York, USA; HCohen{at}kingsbrook.org; HCohenLIU{at}aol.com

Abstract

Objectives This article describes a collaborative survey undertaken along with clinical practitioners in the UK and in Canada, in the fall of 2008. Its purpose was to identify the risks associated with poor labelling of injectable medicines. Additionally, it seeks to make recommendations to improve patient safety through the use of an innovative labelling system, including ‘peelable labels with patient-specific data’ and ‘point-of-use drug information labels’.

Methods In order to assess the use of these labelling systems, clinicians were surveyed regarding their opinions on ‘peelable labels with patient-specific data’ and ‘point-of-use drug information labels’.

Results Practitioners expressed their support for the use of an innovative labelling system, including ‘peelable labels with patient-specific data’ and ‘point-of-use drug information labels’.

Conclusions Due to the deleterious consequences of medication errors, health systems are always seeking ways to improve and prevent these errors. Innovative drug labelling is one mechanism that can be used to prevent errors. A ‘peelable label with patient-specific data’ can be affixed to a syringe. This is one proposed mechanism to ensure that patients receive the correct medication and the correct dose. A ‘point-of-use drug information label’ provides clinicians with drug information at the site of treatment, which may prevent mistakes.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.